Guillain-Barré Syndrome Presenting as Pseudo-Cerebellar Syndrome: A Case Report from a Resource-Limited Setting in Sub-Saharan Africa Guillain-Barré Syndrome (GBS) is the most frequent cause of acute ...

Zenocutuzumab--zbco, marketed as BIZENGRI (R), received Breakthrough Therapy Designation from the FDA in October 2025 and was granted accelerated approval in December 2024 for adults with advanced ...

T cells help the body heal from injuries and fight infections. They do this by making proteins called anti-inflammatory ...

An external lung system sustained a patient with severe respiratory failure. Molecular analysis confirmed irreversible lung ...

Patients prescribed a common antibiotic medication had a higher risk of acute respiratory failure than those prescribed comparable drugs, such as amoxicillin, according to research published Nov. 24 ...

Panelists discuss how mineralocorticoid receptor antagonists (MRAs) remain underutilized despite being foundational therapy for heart failure with reduced ejection fraction due to clinician fears of ...

GSK agreed a worldwide exclusive license agreement for a respiratory disease treatment with Empirico. The U.K. pharmaceutical giant on Tuesday said that as part of the agreement it will make an $85 ...

Meritus Medical Center announced today that it has achieved numerous distinctions for exceptional clinical performance from Healthgrades, the No. 1 site Americans use when searching for a doctor or ...

Please provide your email address to receive an email when new articles are posted on . A link was found between GLP-1 receptor agonist use in PAH and significant decreases in mortality, respiratory ...

6.7-Day Improvement in Time to Complete Resolution of All RSV Symptoms for Patients with Chronic Obstructive Pulmonary Disease (COPD), Congestive Heart Failure (CHF), or Age ≥75 Statistically ...